CHICAGO (GenomeWeb) – At the intersection of genomics and proteomics, investigators are doing basic research bent on improving existing immunotherapies and better understanding response.

Attendees at the American Association for Cancer Research heard about just a few of these potential applications during a major symposium on cancer immunotherapy analyses here yesterday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.